SAVANNAH, Georgia — There’s no medical treatment for Charcot-Marie-Tooth (CMT) disease, a debilitating neurologic disorder ...

A recent study by Dr. Jordan Verplank, Assistant Professor in the Department of Anatomy, Physiology, and Genetics at the ...

The Grammy-winning musician went public about living — and performing — with a neurological condition called ...

The designation recognizes strengths in clinical care and research for persons with hereditary neuropathy, also known as Charcot-Marie-Tooth (CMT) disease. HNF will partner with SLU to become a hub ...

The SynGAP Research Fund 501(c)(3) has awarded a pair of grants to Dr. Clement Chow, a geneticist and Associate Professor in the Department of Human Genetics at the University of Utah. These grants ...

(a) The duplication of a small portion of chromosome 17 that causes Charcot-Marie-Tooth syndrome is evident from the appearance of three, rather than two, red signals in this nucleus. The green ...

Recently, the company announced a collaboration with the Charcot–Marie–Tooth Association, a non-profit organization serving the hereditary neuropathy patient community, to validate the role of ...

The next concert in Alan Jackson's farewell tour is on Saturday, Oct. 26, 2024, in Kansas City, Missouri. In this file photo, ...

ACTX-401: Alcyone Therapeutics ACTX-401 is an AAV9-delivered gene replacement therapy for the treatment of a rare form of ...

Jackson will perform at the world’s largest outdoor honky-tonk on April 5 - his last appearance in the Austin area of Texas.

Actio is advancing two lead rare disease programs with first-in-class potential for the treatment of Charcot-Marie-Tooth Disease, Type 2C (CMT2C) and genetic epilepsy. The CMT2C program is ...

Neuropathic osteoarthropathy, otherwise known as Charcot neuroarthropathy, is a chronic, degenerative arthropathy and is associated with decreased sensory innervation. Numerous causes of this ...